Product Description
Product Name: Goserelin Injection
Strength: 3.6 mg
Form: Subcutaneous Implant (Depot Injection)
Category: Gonadotropin-Releasing Hormone (GnRH) Agonist
Indication: Prostate Cancer, Breast Cancer, Endometriosis, Uterine Fibroids
Goserelin 3.6 mg Injection is a long-acting hormonal therapy classified as a gonadotropin-releasing hormone (GnRH) agonist, used to treat various hormone-sensitive conditions. In men, it is primarily used for the management of prostate cancer, while in women it is indicated for the treatment of breast cancer, endometriosis, and uterine fibroids.
Mechanism of Action:
Goserelin works by suppressing the production of sex hormones (testosterone in men and estrogen in women), effectively slowing the growth of hormone-dependent tumors and tissue.
